Immunocore Holdings Plc ADR (IMCR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -27,934 | -21,641 | -180,857 | -127,044 | -86,664 |
| Depreciation Amortization | 4,165 | 2,253 | 9,642 | 7,300 | 5,006 |
| Accounts receivable | -25,049 | -15,416 | -7,078 | -2,322 | -4,171 |
| Accounts payable and accrued liabilities | 14,406 | -1,083 | 13,021 | 4,254 | 1,816 |
| Other Working Capital | -31,425 | -32,752 | -23,110 | -21,307 | -18,623 |
| Other Operating Activity | 15,596 | 27,267 | 56,221 | 29,113 | 20,760 |
| Operating Cash Flow | $-50,241 | $-41,372 | $-132,161 | $-110,006 | $-81,876 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | N/A | 757 | N/A |
| PPE Investments | -590 | -179 | -1,280 | -918 | -408 |
| Other Investing Activity | 161 | 0 | 776 | 21 | 470 |
| Investing Cash Flow | $-429 | $-179 | $-505 | $-141 | $62 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 1,738 | 350 | 312,808 | 313,248 | 316,641 |
| Other Financing Activity | -4,085 | -2,138 | -31,420 | -28,241 | -26,233 |
| Financing Cash Flow | $-2,348 | $-1,787 | $281,388 | $285,006 | $290,408 |
| Exchange Rate Effect | 15,577 | 356 | 22 | 33 | -106 |
| Beginning Cash Position | 298,666 | 319,195 | 178,373 | 178,865 | 181,317 |
| End Cash Position | 261,224 | 276,214 | 327,117 | 353,758 | 389,805 |
| Net Cash Flow | $-37,442 | $-42,982 | $148,745 | $174,893 | $208,488 |
| Free Cash Flow | |||||
| Operating Cash Flow | -50,241 | -41,372 | -132,161 | -110,006 | -81,876 |
| Capital Expenditure | -596 | -185 | -1,386 | -1,007 | -498 |
| Free Cash Flow | -50,838 | -41,557 | -133,547 | -111,013 | -82,374 |